Journal for ImmunoTherapy of Cancer (Nov 2023)

1246 Immune related adverse events to checkpoint inhibitors are associated with altered regulatory T cell phenotypes and resemble CTLA4-deficient patients

  • Douglas B Johnson,
  • Katy Beckermann,
  • Jeffrey Rathmell,
  • James Maiarana,
  • Carissa Elonen,
  • Janet Markle

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.1246
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.